Florida Governor Ron DeSantis has invoked emergency powers to terminate coverage under the state’s AIDS Drug Assistance Program (ADAP), a move that could significantly impact thousands of HIV patients. Starting March 1, 2024, the changes will remove an estimated 10,000 to 16,000 patients from state funding for life-saving medications, prompting strong criticism from healthcare advocates who warn this decision may lead to increased HIV/AIDS cases and loss of life.
Advocates express concern that the emergency rule, which lowers the income eligibility threshold for assistance from 400% of the federal poverty level to just 130%, will create a public health crisis. Under the new guidelines, only individuals or families earning $20,300 per year or less will qualify for coverage, drastically reducing access from the previous income cap of $62,600.
Governor’s Justification and Community Reaction
Governor DeSantis attributed the cuts to federal budget reductions and escalating healthcare costs. Esteban Wood, director of advocacy and legislative affairs for the AIDS Healthcare Foundation (AHF), argues that Florida’s approach is out of sync with national trends, stating, “Florida is making the deepest cuts to AIDS drug assistance of any state in the country.” He emphasized that the state’s decision-making process violated community engagement requirements, which typically mandate a 21-day waiting period before implementing such changes.
Historically, Florida ranks among the top states for new HIV diagnoses, with the Black community facing the greatest impact. Although Black residents constitute only 17% of the state’s population, they represent approximately 40% of HIV/AIDS patients. The impact of these cuts is expected to be particularly dire for this demographic.
Compounding the issue, Florida has also decided to discontinue coverage for Biktarvy, the most widely prescribed HIV medication in the United States, effective immediately. With a manufacturer’s price of around $4,200 for a 30-day supply, the removal of coverage places patients at risk, especially those who have maintained undetectable viral loads, as switching medications could lead to drug resistance.
Legal Challenges and Legislative Action
On February 11, 2024, the state indicated it would follow formal rulemaking processes, prompting AHF to pause its legal challenge. Yet, shortly before a scheduled court hearing, the Department of Public Health utilized emergency powers to eliminate health insurance premium assistance and terminate existing patients’ coverage. This move drew sharp criticism from Michael Weinstein, president of AHF, who described it as a deliberate attempt to sidestep due process.
Weinstein stated, “We still don’t have the documents that actually back up the fact that there is no money, or that this is an emergency. This just represents a reckless disregard for the public health of Florida.” He emphasized the need for immediate court intervention to prevent the harms that could ensue from the cuts, which he predicts will lead to increased infections and more people seeking emergency medical care.
While bipartisan support exists in the Florida Legislature for bridge funding to sustain ADAP coverage, any new legislation would not take effect until the beginning of the state’s next fiscal year on July 1, 2024. Advocates remain hopeful that the courts will act swiftly to protect the rights and health of Floridians reliant on this critical assistance program.
As the situation develops, the potential ramifications of these changes loom large, threatening to undo years of progress in managing HIV/AIDS in the state. Advocates continue to stress that this issue transcends politics, framing it as a humanitarian crisis that demands urgent attention.
